Search results
What Makes CRISPR Therapeutics AG (CRSP) a New Buy Stock
Zacks via Yahoo Finance· 1 year agoCRISPR Therapeutics AG (CRSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing...
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 7 days agoCRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So,...
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance· 1 month agoCRISPR Therapeutics AG (CRSP) closed at $55.02 in the latest trading session, marking a -0.05% move...
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoCRISPR Therapeutics AG (CRSP) closed the most recent trading day at $49.94, moving +0.56% from the...
CRISPR Therapeutics AG's (NASDAQ:CRSP) Share Price Could Signal Some Risk
Simply Wall St. via Yahoo Finance· 10 months agoWith a price-to-sales (or "P/S") ratio of 24.8x CRISPR Therapeutics AG (NASDAQ:CRSP) may be sending...
Institutional investors control 68% of CRISPR Therapeutics AG (NASDAQ:CRSP) and were rewarded last...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Given the large stake in the stock by institutions, CRISPR Therapeutics' stock price...